18f iso
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT00968409)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f iso
- 18f iso-1
- 18f iso-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02762110 | Phase 1 | Oct 1, 2014 | University of Pennsylvania |
| NCT00968656 | Phase 1 | Jan 1, 2009 | Isotrace Technologies, Washington University in St. Louis |
| NCT00968409 | Phase 1 | Jan 1, 2007 | Washington University in St. Louis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Washington University in St. Louis | Academic/Hospital | 2 | 2 | 1 | 2007 |
| Isotrace Technologies | For profit | 1 | 0 | 1 | 2009 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1